BIO International Convention 2026

The BIO International Convention 2026 will take place from June 22 to 25, 2026, at the San Diego Convention Center (USA). The event will be organized by the Biotechnology Innovation Organization (BIO).

With around 20,000 participants, the BIO International Convention is the world’s leading collaboration platform for the biotechnology and pharmaceutical industries. It brings together innovative startups, international investors, and global industry leaders, offering a unique space to network, share knowledge, and drive new projects forward.

It is the key event for the sector’s top decision-makers.

For the BIO International Convention 2026, the key focus areas include some of the fields that are transforming the biotechnology and healthcare sectors, such as artificial intelligence applied to health and digital health, cell and gene therapies, personalized medicine, and next-generation biotherapies. The program will also cover topics such as business development and investment, opportunities in emerging global markets, oncology, and rare diseases, as well as issues related to intellectual property, regulation, and commercialization. Additionally, key aspects such as translational research, patient access to treatments, and health equity will be addressed.

24/06/2026

11:00h-12:00h

The Future of Oncology Trials: Aligning Science, Regulation, and Investment in Overall Survival.

Ubicació: 32AB

Àmbit d’interès: Oncologia

Moderator: 

• Sarah Richards, Independent Science Journalist

Speakers:

• Jared Kelly, JD CEO, Oncolytics
• Ana Limon, PhD, Senior Vice President, Clinical Development and Medical Affairs, Oryzon Genomics
• Andres McAllister, MD, PhD, Chief Medical Officer, BioInvent International AB
• David J. Portman, MD, President of Oncology, LeonaBio

25/06/2026

10:15h-11:15h

Fast-tracking biotech innovation in Europe: how and when

Ubicació: 25BC

Àmbit d’interès: Oportunitats emergents en mercats globals

Moderator: 

• Maria Pilar Aguar Fernandez, MA. Directorate-General Research and Innovation, European Commission

Speakers:

• Carmen Hurtado del Pozo, PhD, Director, European Research, Breakthrough T1D
• Jean-David Malo, Directorate-General Research and Innovation, European Commission
• Jacqueline Phillips, Senior Director, Paediatric Product Development, Johnson & Johnson

Benefits for Participants

• Exclusive preparatory session with IGE and UC San Diego to address challenges, market access priorities, and go-to-market strategies to strengthen your pitch.
• Turnkey service: management of booth setup, maintenance, decoration, and services so you can focus on meetings and presentations.
• Networking with U.S. partners and investors through the BIO One-on-One Partnering platform to schedule 1-to-1 meetings with research centers, universities, and companies.
• Immersion in the San Diego ecosystem through technical visits and meetings with hospitals, universities, public institutions, and companies in the sector.
• Greater credibility and visibility thanks to a booth in a prime location within a national pavilion.
• Support in preparing your partnering activities: assistance in setting up your partnering profile, preparing your key messages, and access to specialized documentation on the U.S. biotechnology sector.
• Dedicated meeting space (partnering format) with a table to meet with medical centers, companies, investors, and research institutions and strengthen business relationships.

Deadline for booth applications: closed.
Deadline for accreditation applications: until April 30.